These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31407113)

  • 1. Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies.
    Muntoni E; Marini E; Ahmadi N; Milla P; Ghè C; Bargoni A; Capucchio MT; Biasibetti E; Battaglia L
    Acta Diabetol; 2019 Dec; 56(12):1283-1292. PubMed ID: 31407113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms.
    Muntoni E; Anfossi L; Milla P; Marini E; Ferraris C; Capucchio MT; Colombino E; Segale L; Porta M; Battaglia L
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):691-698. PubMed ID: 33131992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
    Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O
    Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.
    Ranpise NS; Korabu SS; Ghodake VN
    Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles.
    Zhang Y; Li Z; Zhang K; Yang G; Wang Z; Zhao J; Hu R; Feng N
    Int J Pharm; 2016 Sep; 511(1):57-64. PubMed ID: 27374194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation.
    Paudel A; Ameeduzzafar ; Imam SS; Fazil M; Khan S; Hafeez A; Ahmad FJ; Ali A
    Curr Drug Deliv; 2017; 14(7):1005-1015. PubMed ID: 28034361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies.
    Gadhave DG; Kokare CR
    Drug Dev Ind Pharm; 2019 May; 45(5):839-851. PubMed ID: 30702966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paliperidone-Loaded Nanolipomer System for Sustained Delivery and Enhanced Intestinal Permeation: Superiority to Polymeric and Solid Lipid Nanoparticles.
    Helal HM; Mortada SM; Sallam MA
    AAPS PharmSciTech; 2017 Aug; 18(6):1946-1959. PubMed ID: 27914041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles.
    Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R
    Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
    Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
    J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
    Gadhave DG; Tagalpallewar AA; Kokare CR
    AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations.
    Jain S; Addan R; Kushwah V; Harde H; Mahajan RR
    Int J Pharm; 2019 May; 562():96-104. PubMed ID: 30902706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles.
    Alsulays BB; Anwer MK; Soliman GA; Alshehri SM; Khafagy ES
    Int J Nanomedicine; 2019; 14():9127-9138. PubMed ID: 31819423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
    Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
    Rizwanullah M; Amin S; Ahmad J
    J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.